Decompensation in heart failure (HF) often begins weeks before symptoms are apparent, but interventions are typically reactive. A new trial tested whether combining a multiparameter sensor-based algorithm with a mobile health (mHealth) solution could improve patient engagement and outcomes. Findings for the same were presented at the European Society of Cardiology (ESC) Congress 2025.

The algorithm uses data from implantable cardiac electronic devices to predict HF deterioration with a median 34-day lead time. Unlike current workflows, which focus on clinician alerts, this study provided weekly algorithm-driven feedback directly to patients through a traffic-light system. Green indicated stability, amber encouraged vigilance, and red prompted clinical review if symptoms were present.

The study included 160 participants with heart failure and algorithm-enabled devices, split between mobile health integration and standard care. At six months, the mHealth group showed significantly improved functional capacity, with a 27-meter increase in the 6-minute walk test versus a decline of 6 meters in controls (p=0.01). Alerts in the mHealth arm were shorter in duration, suggesting faster resolution. Trends also indicated better medication adherence, lower NT-proBNP levels, and reduced risk scores. However quality-of-life scores did not differ between groups.

Importantly, usability and feasibility of the mHealth intervention remained consistent across all age groups, confirming its scalability.

These results suggest that an algorithm-driven, patient-centered mHealth pathway can support earlier responses, improve functional outcomes, and enhance patient self-management in HF. Ongoing follow-up will clarify the durability of these benefits.